Vivo Bio Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1. To consider and approve the ....

Strategic Transactions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.6%Reaction day

₹28.30

prior close

₹28.58

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-5.3% vs market

Pharmaceuticals & Biotechnology peers, median of 169sector · industry level+0.2%-4.7% vs sector

On the reaction day the stock moved 5.3 pts less than Nifty Microcap 250 and 4.7 pts less than its Pharmaceuticals & Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-5.5

10m

-2.2

15m

-2.2

30m

-3.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.6+0.7-5.3+0.2-4.7

Next day

-5.1+0.7-5.8-0.1-5.0

-2.1+0.0-2.2-0.3-1.8

-13.4-1.1-12.4-1.3-12.1

-18.4+0.0-18.4-1.2-17.2

-16.6+0.3-16.9-1.4-15.2

-13.5+1.1-14.6-0.5-13.0

15d

-15.1+4.9-20.0-0.3-14.8

-17.1+5.3-22.4+2.6-19.7

-19.3+6.9-26.2+3.9-23.3

—+11.9—+7.1—

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals & Biotechnology peers, median of 169Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vivo Bio Tech Ltd has informed BSE that its Board of Directors meeting is scheduled for May 29, 2026. The meeting will consider and approve two items: (1) the Audited Standalone and Consolidated Financial Results for Q4 and the year ended March 31, 2026, and (2) the amalgamation of Shri Shri Resorts Private Limited (Transferor Company) into Vivo Bio Tech Limited (Transferee Company). The amalgamation will be pursued under Sections 230 to 232 of the Companies Act, 2013 and SEBI Listing Regulations. The trading window for insiders will remain closed until May 31, 2026.

Likely market impact

The proposed amalgamation of Shri Shri Resorts Private Limited into Vivo Bio Tech Limited could signal corporate restructuring activity. If approved, this may lead to future share transfers or dilution affecting existing shareholders. Regular Q4 results approval is standard procedure.